Home / India News / Strides Shasun intimates of successful USFDA inspection of Cuddalore manufacturing facility

Strides Shasun intimates of successful USFDA inspection of Cuddalore manufacturing facility

Last Updated : Apr 25 2017 | 12:03 AM IST

Receives Zero 483 observations

Strides Shasun announced that its API manufacturing site at Cuddalore was recently inspected by US FDA. The Company has successfully completed this inspection with Zero 483 observations.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Also Read

Strides Shasun's Cuddalore plant completes USFDA inspection

Alkem Laboratories intimates of successful USFDA Bio-analytical Inspection

Strides Shasun R&D unit gets USFDA inspection closure report

Alembic Pharmaceuticals intimates of successful inspection of its Baroda facility

Marksans Pharma intimates of USFDA inspection of its manufacturing facility at Goa

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 24 2017 | 7:36 PM IST

Explore News

Market LIVE Market Today Sai Life Sciences IPO Parliament Winter Session 2024 LIVE Latest News LIVE Stocks To Watch Today Process to withdraw PF by ATM Gold-Silver Price Today IPO News Business Standard at 50